米纳瑞斯制药 MLYS
$15.33 +$0.09 (+0.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.33 0.00%
开盘$15.23
昨收$15.24
当日区间$14.91 – $15.65
成交量1.34M
市值$1.36B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$246.04M-426.3% YoY
净利润-$241.07M-457.1% YoY
摊薄每股收益-$2.85-331.8% YoY
自由现金流-$32.56M-7.9% YoY
经营现金流-$32.56M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-80.9%
资产收益率-69.7%
投入资本回报率-85.8%
流动比率34.46
负债/资产比率17.5%
现金及投资$661.41M
净现金（净负债）$661.41M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $246.04M | $45.34M | $170.60M | $38.28M | $41.13M |
| 销售及管理费用 | $24.66M | $20.98M | $38.60M | $13.88M | $9.68M |
| -管理费用 | $24.66M | $20.98M | $38.60M | $13.88M | $9.68M |
| 研发费用 | $221.38M | $24.37M | $132.01M | $24.40M | $31.45M |
| 营业利润 | -$246.04M | -$45.34M | -$170.60M | -$38.28M | -$41.13M |
| 非经营性利息净收入（支出） | $4.96M | $6.00M | $15.95M | $6.05M | $4.20M |
| 非经营性利息收入 | $4.96M | $6.00M | $15.95M | $6.05M | $4.20M |
| 其他收入（支出） | $13,000.00 | $5,000.00 | – | – | $4,000.00 |
| 其他非经营性收入（支出） | $13,000.00 | $5,000.00 | – | – | $4,000.00 |
| 税前利润 | -$241.07M | -$39.34M | -$154.65M | -$32.23M | -$36.93M |
| 净利润 | -$241.07M | -$39.34M | -$154.65M | -$32.23M | -$36.93M |
| 持续经营利润 | -$241.07M | -$39.34M | -$154.65M | -$32.23M | -$36.93M |
| 归属母公司净利润 | -$241.07M | -$39.34M | -$154.65M | -$32.23M | -$36.93M |
| 归属普通股股东净利润 | -$241.07M | -$39.34M | -$154.65M | -$32.23M | -$36.93M |
| 基本每股收益 | -$2.85 | -$0.47 | -$2.29 | -$0.40 | -$0.52 |
| 摊薄每股收益 | -$2.85 | -$0.47 | -$2.29 | -$0.40 | -$0.52 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $667.85M | $652.86M | $661.81M | $661.81M | $599.95M |
| 流动资产合计 | $665.80M | $652.47M | $661.39M | $661.39M | $599.80M |
| 现金及现金等价物与短期投资 | $661.41M | $646.06M | $656.64M | $656.64M | $593.63M |
| -现金及现金等价物 | $138.27M | $112.78M | $172.92M | $172.92M | $217.60M |
| -短期投资 | $523.14M | $533.28M | $483.71M | $483.71M | $376.03M |
| 其他流动资产 | $4.39M | $6.41M | $4.75M | $4.75M | $6.17M |
| 非流动资产合计 | $2.05M | $392,000.00 | $420,000.00 | $420,000.00 | $151,000.00 |
| 固定资产净值 | $27,000.00 | $32,000.00 | $38,000.00 | $38,000.00 | $7,000.00 |
| 其他非流动资产 | $2.02M | $360,000.00 | $382,000.00 | $382,000.00 | $144,000.00 |
| 负债合计 | $116.94M | $14.72M | $15.11M | $15.11M | $23.52M |
| 流动负债合计 | $19.32M | $14.72M | $15.11M | $15.11M | $23.52M |
| 应付款 | $1.07M | $1.12M | $2.02M | $2.02M | $1.12M |
| -应付账款 | $1.07M | $1.12M | $2.02M | $2.02M | $1.12M |
| 一年内应计费用 | $14.06M | $11.29M | $7.56M | $7.56M | $18.52M |
| 非流动负债合计 | $97.62M | $0.00 | $0.00 | $0.00 | $0.00 |
| 股东权益合计 | $550.92M | $638.14M | $646.69M | $646.69M | $576.43M |
| 股东权益 | $550.92M | $638.14M | $646.69M | $646.69M | $576.43M |
| 股本 | $9,000.00 | $8,000.00 | $8,000.00 | $8,000.00 | $8,000.00 |
| -普通股 | $9,000.00 | $8,000.00 | $8,000.00 | $8,000.00 | $8,000.00 |
| 资本公积 | $1.29B | $1.13B | $1.10B | $1.10B | $1.00B |
| 留存收益 | -$737.58M | -$496.51M | -$457.17M | -$457.17M | -$424.94M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$32.56M | -$39.47M | -$142.42M | -$37.89M | -$28.87M |
| 持续经营经营活动现金流净额 | -$32.56M | -$39.47M | -$142.42M | -$37.89M | -$28.87M |
| 持续经营净利润 | -$241.07M | -$39.34M | -$154.65M | -$32.23M | -$36.93M |
| 折旧、折耗与摊销 | $5,000.00 | $6,000.00 | $59,000.00 | $13,000.00 | $15,000.00 |
| 其他非现金项目 | $195.48M | -$4.63M | -$9.88M | -$4.21M | -$2.40M |
| 营运资金变动 | $5.67M | -$2.06M | $2.73M | -$6.74M | $4.60M |
| -应收款变动 | $47,000.00 | $289,000.00 | -$166,000.00 | -$181,000.00 | $10,000.00 |
| -预付资产变动 | $1.96M | -$1.95M | $2.47M | $1.57M | $3.56M |
| -应付账款及应计费用变动 | $3.67M | -$402,000.00 | $427,000.00 | -$8.13M | $1.03M |
| 投资活动现金流净额 | -$185.22M | -$44.94M | -$389.75M | -$103.49M | -$150.51M |
| 持续经营投资活动现金流净额 | -$185.22M | -$44.94M | -$389.75M | -$103.49M | -$150.51M |
| 投资购置及出售净额 | $14.78M | -$44.94M | -$389.74M | -$103.47M | -$150.51M |
| 筹资活动现金流 | $243.26M | $24.27M | $591.00M | $96.70M | $295.19M |
| 持续经营筹资活动现金流净额 | $243.26M | $24.27M | $591.00M | $96.70M | $295.19M |
| 普通股发行净额 | $143.90M | $20.22M | $578.36M | $91.95M | $288.59M |
| 股票期权行使所得 | $2.90M | $4.06M | $13.03M | $5.06M | $6.62M |
| 其他筹资费用净额 | -$1.03M | -$1,000.00 | -$391,000.00 | -$305,000.00 | -$29,000.00 |
| 期末现金余额 | $138.27M | $112.78M | $172.92M | $172.92M | $217.60M |
| 现金净变动 | $25.49M | -$60.14M | $58.83M | -$44.68M | $115.81M |
| 期初现金余额 | $112.78M | $172.92M | $114.09M | $217.60M | $101.79M |
| 自由现金流 | -$32.56M | -$39.47M | -$142.43M | -$37.90M | -$28.87M |
| 固定资产购置及出售净额 | – | – | -$15,000.00 | -$15,000.00 | – |
暂无评论——快来第一个聊聊 MLYS。
登录后参与讨论。